TrianglePUBLICATIONS · 12933575
A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2003 Dec 15
- First author
- Kell WJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kell WJ
- type
- Author
- name
- Burnett AK
- type
- Author
- name
- Chopra R
- type
- Author
- name
- Yin JA
- type
- Author
- name
- Clark RE
- type
- Author
- name
- Rohatiner A
- type
- Author
- name
- Culligan D
- type
- Author
- name
- Hunter A
- type
- Author
- name
- Prentice AG
- type
- Author
- name
- Milligan DW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kell WJ
- type
- Author
- name
- Burnett AK
- type
- Author
- name
- Chopra R
- type
- Author
- name
- Yin JA
- type
- Author
- name
- Clark RE
- type
- Author
- name
- Rohatiner A
- type
- Author
- name
- Culligan D
- type
- Author
- name
- Hunter A
- type
- Author
- name
- Prentice AG
- type
- Author
- name
- Milligan DW
- type
- Author
- bibliography ids
- nci-bib-dad348a3be7f0b3d35782553
- book metadata
- content sha256
- e14141625cc041ff335e6eccb639c24dd7232729717cfb825acfa2a0668126b2
- document type
- citation
- dois
- 10.1182/blood-2003-05-1620
- electronic publication date
- display
- 2003 Aug 21
- precision
- day
- year
- 2003
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12933575
- immutable id
- pubmed:12933575@e14141625cc041ff335e6eccb639c24dd7232729717cfb825acfa2a0668126b2
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 13
- name
- Blood
- nlm unique id
- 7603509
- pages
- 4277-83
- volume
- 102
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12933575
- provenance
- batch id
- 2d0158fe73b50bb1a4bf
- provider
- NCBI PubMed ESummary
- record sha256
- 1b9812f8fc4c4c5dffa50381535927496959171d5e9732c58a00a6c636f25d84
- response sha256
- d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
- retrieved at
- 2026-09-09T23:45:50.935339+00:00
- publication date
- display
- 2003 Dec 15
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Controlled Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia.
Preserved source evidence · Not medical advice